Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00880204
What this trial is testing

Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training

Who this might be right for
SepsisAsthmaHeart Failure+2 more
Child Advocacy International 36
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Early research (Phase 1)Looking for participantsNCT07219563
What this trial is testing

Alnuctamab for Refractory SLE (LATTE Study)

Who this might be right for
Systemic Lupus Erythematosus
Icahn School of Medicine at Mount Sinai 21
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Early research (Phase 1)Study completedNCT02359292
What this trial is testing

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 50
Not applicableStudy completedNCT00513487
What this trial is testing

Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity

Who this might be right for
Allergic Rhinitis
Novartis 18
Not applicableLooking for participantsNCT06682507
What this trial is testing

High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

Who this might be right for
Lupus Nephritis (LN)
First Affiliated Hospital, Sun Yat-Sen University 5,000
Not applicableLooking for participantsNCT06210698
What this trial is testing

Angioedema Biomarker Research Study

Who this might be right for
AngioedemaAngioedemas, HereditaryUrticaria+5 more
Foundation For Rare Disease Research 600
Not applicableEnded earlyNCT03489577
What this trial is testing

The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients

Who this might be right for
Multiple TraumaSepsisInnate Immune Response+2 more
UMC Utrecht 15
Testing effectiveness (Phase 2)Ended earlyNCT05168475
What this trial is testing

Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis

Who this might be right for
Giant Cell ArteritisTakayasu ArteritisCogan Syndrome+6 more
Cambridge University Hospitals NHS Foundation Trust 22
Not applicableLooking for participantsNCT07121777
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Anhui Provincial Hospital 18
Large-scale testing (Phase 3)Study completedNCT00268567
What this trial is testing

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Who this might be right for
Nephritis, Lupus
Peking University
Not applicableStudy completedNCT04397107
What this trial is testing

The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases

Who this might be right for
Systemic Lupus Erythematosus
The First Hospital of Jilin University 46
Testing effectiveness (Phase 2)Study completedNCT00426764
What this trial is testing

A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Celgene 131
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Early research (Phase 1)Study completedNCT06955598
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Not applicableStudy completedNCT02950714
What this trial is testing

Dissemination of the Lupus Interactive Navigator

Who this might be right for
Systemic Lupus Erythematosus
CHU de Quebec-Universite Laval 541
Large-scale testing (Phase 3)Study completedNCT01203345
What this trial is testing

Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

Who this might be right for
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more
NICHD Neonatal Research Network 2,416
Testing effectiveness (Phase 2)Study completedNCT02320357
What this trial is testing

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

Who this might be right for
Systemic Lupus Erythematous
University Hospital, Bordeaux 18
Testing effectiveness (Phase 2)Study completedNCT01449071
What this trial is testing

Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 20
Next Page